198 related articles for article (PubMed ID: 34629716)
1. Radioembolization in the Setting of Systemic Therapies.
Mabud TS; Hickey R
Semin Intervent Radiol; 2021 Oct; 38(4):472-478. PubMed ID: 34629716
[No Abstract] [Full Text] [Related]
2. History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
Saini A; Wallace A; Alzubaidi S; Knuttinen MG; Naidu S; Sheth R; Albadawi H; Oklu R
J Clin Med; 2019 Jan; 8(1):. PubMed ID: 30621040
[TBL] [Abstract][Full Text] [Related]
3. Study Protocol: Efficacy and Safety of Radioembolization (REM) as an Early Modality (EM) Therapy for Metastatic Breast Cancer (BR) to the Liver with Y90 (REMEMBR Y90).
Wu R; Gogineni K; Meisel J; Szabo S; Thirunavu M; Friend S; Bercu Z; Sethi I; Natarajan N; Switchenko J; Levy J; Abdalla E; Weakland L; Kalinsky K; Kokabi N
Cardiovasc Intervent Radiol; 2022 Nov; 45(11):1725-1734. PubMed ID: 36008574
[TBL] [Abstract][Full Text] [Related]
4. Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis.
Maker AV; August C; Maker VK; Weisenberg E
J Gastrointest Surg; 2016 Apr; 20(4):869-70. PubMed ID: 26847353
[TBL] [Abstract][Full Text] [Related]
5. Yttrium-90 microsphere radioembolization for hepatocellular carcinoma.
Edeline J; Gilabert M; Garin E; Boucher E; Raoul JL
Liver Cancer; 2015 Mar; 4(1):16-25. PubMed ID: 26020026
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Combined Yttrium 90 Resin Radioembolization with Aflibercept and FOLFIRI in a Patient with Metastatic Colorectal Cancer.
De Souza A; Daly KP; Yoo J; Saif MW
Case Rep Oncol Med; 2015; 2015():461823. PubMed ID: 25866690
[TBL] [Abstract][Full Text] [Related]
7. Yttrium-90 for colorectal liver metastasis - the promising role of radiation segmentectomy as an alternative local cure.
Entezari P; Gabr A; Salem R; Lewandowski RJ
Int J Hyperthermia; 2022; 39(1):620-626. PubMed ID: 35465813
[TBL] [Abstract][Full Text] [Related]
8. Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system.
Damm R; Seidensticker R; Ulrich G; Breier L; Steffen IG; Seidensticker M; Garlipp B; Mohnike K; Pech M; Amthauer H; Ricke J
BMC Cancer; 2016 Jul; 16():509. PubMed ID: 27439702
[TBL] [Abstract][Full Text] [Related]
9. Impact of Genomic Mutation and Timing of Y90 Radioembolization in Colorectal Liver Metastases.
Dabrowiecki A; Sankhla T; Shinn K; Bercu ZL; Ermentrout M; Shaib W; Cardona K; Newsome J; Kokabi N
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1006-1014. PubMed ID: 32367230
[TBL] [Abstract][Full Text] [Related]
10. Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy.
Lewandowski RJ; Memon K; Mulcahy MF; Hickey R; Marshall K; Williams M; Salzig K; Gates VL; Atassi B; Vouche M; Atassi R; Desai K; Hohlastos E; Sato K; Habib A; Kircher S; Newman SB; Nimeiri H; Benson AB; Salem R
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1861-9. PubMed ID: 24906565
[TBL] [Abstract][Full Text] [Related]
11. SIR-Spheres yttrium-90 radioembolization for the treatment of unresectable liver cancers.
Golfieri R
Hepat Oncol; 2014 Jun; 1(3):265-283. PubMed ID: 30190962
[TBL] [Abstract][Full Text] [Related]
12. Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient Cohort.
Gupta AN; Gordon AC; Gabr A; Kalyan A; Kircher SM; Mahalingam D; Mulcahy MF; Merkow RP; Yang AD; Bentrem DJ; Caicedo-Ramirez JC; Riaz A; Thornburg B; Desai K; Sato KT; Hohlastos ES; Kulik L; Benson AB; Salem R; Lewandowski RJ
Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1117-1128. PubMed ID: 35732931
[TBL] [Abstract][Full Text] [Related]
13. Consensus statement on safety of combining transarterial radioembolization with
Kennedy AS; Brown DB; Fakih M; Jeyarajah R; Jones S; Liu D; Pinato DJ; Sangro B; Sharma NK; Sze DY; Van Cutsem E; Wasan HS
J Vasc Interv Radiol; 2024 Jun; ():. PubMed ID: 38885899
[TBL] [Abstract][Full Text] [Related]
14. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma.
Wehrenberg-Klee E; Gandhi RT; Ganguli S
Tech Vasc Interv Radiol; 2019 Jun; 22(2):70-73. PubMed ID: 31079713
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection.
Ali R; Riaz A; Gabr A; Abouchaleh N; Mora R; Al Asadi A; Caicedo JC; Abecassis M; Katariya N; Maddur H; Kulik L; Lewandowski RJ; Salem R
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2195-2202. PubMed ID: 28812136
[TBL] [Abstract][Full Text] [Related]
16. Yttrium-90 Radioembolization for Metastatic Colorectal Cancer: Outcomes by Number of Lines of Therapy.
Marsala A; Lee EW; Padia SA
Semin Intervent Radiol; 2017 Jun; 34(2):116-120. PubMed ID: 28579679
[TBL] [Abstract][Full Text] [Related]
17. Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT).
Helmberger T; Golfieri R; Pech M; Pfammatter T; Arnold D; Cianni R; Maleux G; Munneke G; Pellerin O; Peynircioglu B; Sangro B; Schaefer N; de Jong N; Bilbao JI; ;
Cardiovasc Intervent Radiol; 2021 Jan; 44(1):21-35. PubMed ID: 32959085
[TBL] [Abstract][Full Text] [Related]
18. Radioembolization for the Treatment of Primary and Metastatic Liver Cancers.
Lee EJ; Chung HW; Jo JH; So Y
Nucl Med Mol Imaging; 2019 Dec; 53(6):367-373. PubMed ID: 31867071
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in France.
Garin E; Pinaquy JB; Bailly C; Sengel C; Mariano-Goulart D; Edeline J; Blanc JF; Bouvier A; Tordo J; Rode A; Becker S; Sefrioui D; de Baere T; Somma C; Mastier C; Goupil J; Chevallier P; Regnault H; Vibert E; Manfredi S; Vicaut E; Patel B; Boucher E; Guiu B;
Cardiovasc Intervent Radiol; 2022 Jan; 45(1):1-11. PubMed ID: 34796373
[TBL] [Abstract][Full Text] [Related]
20. Liver-directed treatments of liver-dominant metastatic leiomyosarcoma.
Krzyston H; Morse B; Deperalta D; Rishi A; Kayaleh R; El-Haddad G; Smith J; Druta M; Kis B
Diagn Interv Radiol; 2020 Sep; 26(5):449-455. PubMed ID: 32673206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
